Macrolides in cystic fibrosis


Autoria(s): Bell, S. C.; Senini, S. L.; McCormack, J. G.
Contribuinte(s)

C. Rochester

M. Morgan

S. Singh

Data(s)

01/01/2005

Resumo

Three randomized control trials have recently been published which have studied the effect of the macrolide antibiotic, azithromycin, in patients with cystic fibrosis (CF).1 3 This review examines the history of macrolide development, antimicrobial indications for macrolides, potential immunomodulatory effects of macrolides and evidence for the role of macrolides in lung diseases, including CE

Identificador

http://espace.library.uq.edu.au/view/UQ:76952

Idioma(s)

eng

Publicador

Hodder Arnold Journals

Palavras-Chave #azithromycin #cystic fibrosis #diffuse pan bronchiolitis #inflammation #macrolides #C1 #320401 Medical Bacteriology #730110 Respiratory system and diseases (incl. asthma)
Tipo

Journal Article